Top

Published in:

01-08-2010

Factors in Selecting the Optimal Bariatric Procedure for a Specific Patient and Parameters by Which to Measure Appropriate Response to Surgery

Authors: Clifford W. Deveney, Robert G. Martindale

Published in: Current Gastroenterology Reports | Issue 4/2010

Abstract

Bariatric operations are increasingly being used to induce weight loss and ameliorate or cure most of the morbidities that accompany obesity. These procedures not only produce substantial weight loss (>50% body weight), but they cure or ameliorate the comorbidities (diabetes type 2, hypertension, sleep apnea, hyperlipidemia) in the vast majority of patients. These procedures can usually be performed laparoscopically with a mortality of less than 0.5% and a hospital stay of 1 to 3 days. Presently they are the only effective treatment for weight loss in the extremely obese patient (body mass index ≥ 35).

Solomon CG, Manson JE: Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997, 66(Suppl):10444S–10450S.

Ogden CL, Carroll MD, Flegal KM, et al.: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295(13):1549–1555.CrossRefPubMed

Friedrich MJ: Epidemic of obesity expands its spread to developing countries. JAMA 2002, 287(11):1382–1386.CrossRefPubMed

Nguyen NT, Magno CP, Lane KT, et al.: Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008, 207(6):928–934.CrossRefPubMed

• Stewart ST, Cutler DM, Rosen AB: Forecasting the effects of obesity and smoking on US life expectancy. N Engl J Med 2009, 361(123):2252–2260. This article describes an epidemiology study documenting the effect of obesity on longevity.CrossRefPubMed

Picot J, Jones J, Clegg AJ, et al.: The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009, 13(41):1–190, 215–357.

•• Keating CL, Dixon JB, O’Brien PE: Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care 2009, 32(4):580–4. This article presents a cost analysis of bariatric surgery versus medical therapy for treatment of type 2 diabetes mellitus. This is a randomized, controlled study. Over 15 years, the cost was slightly less for surgically treated patients and the diabetes was more effectively treated in the surgical therapy group.CrossRefPubMed

Christou NV, Sampalis JS, MacLean LD, et al.: Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004, 240(3):416–424.CrossRefPubMed

• Adams TD, Gress RE, Hunt SC, et al.: Long-term mortality after gastric bypass surgery. N Engl J Med 2007, 357(8):753–761. This article describes a retrospective study examining two large cohorts matched for age, sex, and BMI. One cohort had a bariatric procedure; the other cohort was not treated with surgery. Long-term mortality was reduced in the cohort undergoing a bariatric procedure.CrossRefPubMed

10.

Maru S, van Der Schouw YT, Peeters PHM, et al.: Body mass index and short-term weight change in relation to mortality in Dutch women after age 50. Am J Clin Nutr 2004, 80:231–236.PubMed

11.

•• Sjostrom L, Narbro K, Carlsson L, et al.: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357(8):741–752. This article describes a prospective study with more than 2000 patients in each group of obese patients. One group had bariatric surgery, the other did not. Mortality was decreased and weight loss increased in those patients undergoing bariatric surgery. The first prospective study demonstrating increased long-term survival following bariatric surgery.CrossRefPubMed

12.

Martin LF: The evolution of surgery for morbid obesity. In Obesity Surgery. Edited by Martin LF. New York: McGraw Hill; 2004:15–48.

13.

Gastrointestinal Surgery for Severe Obesity. NIH Consensus Development Conference Statement March 25–27, 1991.

14.

• Farrell TM, Overby DW, Richardson WS: Clinical application of laparoscopic bariatric surgery: an evidence-based review. Surg Endosc 2009, 23:920–949. This article is a well-documented review outlining the present bariatric procedures, their advantages, and drawbacks.CrossRef

15.

Buchwald H, Avidor Y, Schoelles K, et al.: Bariatric surgery: A systematic review and meta-analysis. JAMA 2004, 292(14):1724–1737.CrossRefPubMed

16.

Nguyen NT, Goldman C, Rosenquist J, et al.: Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001, 234:279.CrossRefPubMed

17.

•• The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium: Perioperative safety in the longitudinal assessment of bariatric surgery. N ENGL J MED 2009, 361(5):445–454. This prospective study compared the safety of LAGB, RYGBP, and BPD performed at six centers in the United States.CrossRef

18.

Salameh JR: Bariatric surgery: past and present. Am J Med Sci 2006, 331(4):194–200.CrossRefPubMed

19.

Mason EE, Ito C: Gastric bypass. Ann Surg 1969, 170:329.CrossRefPubMed

20.

Griffen WO, Young VL, Stevenson CC: A prospective comparison of gastric and jejuno-ileal bypass procedures for morbid obesity. Ann Surg 1977, 186(4):500–509.CrossRefPubMed

21.

Martin LF: Gastric restrictive procedures: gastroplasties and bands. In Obesity Surgery. Edited by Martin LF. New York: McGraw Hill; 2004:193–200.

22.

Chapman AE, Kiroff G, Game P, et al.: Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surg 2004, 135(3):326–351.CrossRef

23.

Mittermair RP, Obermuller S, Margreiter R, et al.: Results and complications after Swedish adjustable gastric banding—10 years experience. Obes Surg 2009, 19(12)1636–1641.CrossRefPubMed

24.

Fuks D, Verhaeghe P, Brehant O: Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surg 2009, 145(1):106–113.CrossRef

25.

Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al.: Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010 2010, 20(5):535–540.

26.

Deitel M, Crosby RD, Gagner M: The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg 2008, 18:487–496.CrossRefPubMed

27.

Gumbs AA, Gagner M, Dakin G, Pomp A: Sleeve gastrectomy for morbid obesity. Obes Surg 2007, 17(7):962–969.CrossRefPubMed

28.

Prachand VN, Ward M, Alverdy JC: Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or + 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 2010, 14(2):211–220.CrossRefPubMed

29.

Søvik TT, Taha O, Aasheim ET, et al.: Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg 2010, 97(2):160–166.CrossRefPubMed

30.

Strain GW, Gagner M, Pomp A, et al.: Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis 2009, 5(5):582–587.CrossRefPubMed

31.

Lynch RJ, Eisenberg D, Bell RL: Metabolic consequences of bariatric surgery. J Clin Gastroenterol 2006, 40(8):659–668.CrossRefPubMed

32.

Wee CC: A 52-year-old woman with obesity: review of bariatric surgery. JAMA 2009, 302(10):1097–1104.CrossRefPubMed

33.

•• Tice JA, Karliner L, Feldman MD, et al.: Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008, 121(10):885–893. A timely meta-analysis of studies comparing LRYGBP with LAGB. The study slightly favors LRYGBP.CrossRefPubMed

34.

Jones DB, Provost DA, Schirmer B, et al.: Optimal management of the morbidly obese patient. Surg Endosc 2004, 18:1029–1037.CrossRefPubMed

35.

Needleman BJ, Happel LC: Bariatric surgery: Choosing the optimal procedure. Surg Clin N Am 2008, 88:991–1007.CrossRefPubMed

36.

Favretti F, Ashton D, Busetto L, et al.: The gastric band: first-choice procedure for obesity surgery. World J Surg 2009, 33(10):2039–2048.CrossRefPubMed

37.

Christou N, Efthimiou E: Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada. Can J Surg 2009, 52(6):E249–E258.PubMed

38.

Treadwell JR, Sun F, Schoelle K: Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg 2008, 248(5):763–776.CrossRefPubMed

39.

Varela JE, Wilson SE, Nguyen NT: Outcomes of bariatric surgery in the elderly. Am Surg 2006, 72(10):865–869.PubMed

40.

Hollenbeak CS, Rogers A, Barrus B, et al.: Surgical volume impacts bariatric surgery mortality: a case for centers of excellence. Surgery 2008, 144(5):736–743.CrossRefPubMed

41.

Nguyen NT, Root J, Zainabadi K, et al.: Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg 2005, 140:1198–1202.CrossRefPubMed

42.

Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 2006, 331(4):219–225.CrossRefPubMed

43.

Toh SY, Zarshenas N, Jorgensen J: Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009, 25:1150–1156.CrossRefPubMed

44.

• Aasheim ET: Wernicke encephalopathy after bariatric surgery. Ann Surg 2008, 248:714–720. Survey documenting the incidence of Wernicke’s encephalopathy following bariatric surgery. Although a rare complication, it can be devastating.PubMed

45.

Duffrey BG, Pedro RN, Makhlouf A, et al.: Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg 2008, 206(6):1145–1153.CrossRef

46.

Sinha MK, Collazo-Clavell ML, Rule A, et al.: Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Internat 2007, 72:100–107.CrossRef

47.

DeMaria EJ: Bariatric surgery for morbid obesity. N Engl J Med 2007, 356(21):2176–2183.CrossRefPubMed

Title: Factors in Selecting the Optimal Bariatric Procedure for a Specific Patient and Parameters by Which to Measure Appropriate Response to Surgery
Authors: Clifford W. Deveney
Robert G. Martindale
Publication date: 01-08-2010
Publisher: Current Science Inc.
Published in: Current Gastroenterology Reports / Issue 4/2010
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-010-0117-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Factors in Selecting the Optimal Bariatric Procedure for a Specific Patient and Parameters by Which to Measure Appropriate Response to Surgery

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Childhood Obesity: Update on Predisposing Factors and Prevention Strategies

Clinical Trial Report: Eradication of Helicobacter pylori and MALT Lymphoma: Where Do We Stand?

The Noncolonic Microbiome: Does it Really Matter?

Whipple’s Disease: A Rare Disease Revisited

Micronutrient-Related Neurologic Complications Following Bariatric Surgery

The Dysfunctional Gut

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page